Gray J M, Wade G N
Am J Physiol. 1981 May;240(5):E474-81. doi: 10.1152/ajpendo.1981.240.5.E474.
A series of experiments examined the effects of two progestins, progesterone and R 5020, and two nonsteroidal antiestrogens, nafoxidine and MER-25, on body weight and composition in female rats. Both progesterone and R 5020 increased food intake, body weight, and carcass adiposity in ovariectomized (OVX) rats treated with estradiol benzoate (EB), but neither progestin had any effect on these measures in OVX rats not treated with EB. R 5020 was substantially more effective than progesterone on all end points. Nafoxidine and MER-25 mimicked the actions of estradiol and decreased adipose tissue lipoprotein lipase (LPL) activity by 75-80%. For adipose tissue LPL activity, both nafoxidine and MER-25 were full estrogen agonists and without antiestrogenic activity. Nafoxidine also mimicked the effects of EB by reducing food intake, body weight, and carcass adiposity in OVX rats. In contrast, nafoxidine antagonized the induction of cytoplasmic progestin ([3H]R 5020) binding sites by EB in parametrial adipose tissue of OVX rats. In nafoxidine-treated OVX rats, concurrent progesterone administration had no effect on adipose tissue LPL activity, but progesterone did increase food intake, body weight, and carcass fat content. Some physiological mechanisms by which gonadal steroids may act to influence eating and adiposity are discussed.
一系列实验研究了两种孕激素(孕酮和R 5020)以及两种非甾体抗雌激素(萘福昔定和MER - 25)对雌性大鼠体重和身体组成的影响。孕酮和R 5020均可增加接受苯甲酸雌二醇(EB)治疗的去卵巢(OVX)大鼠的食物摄入量、体重和胴体脂肪含量,但在未接受EB治疗的OVX大鼠中,这两种孕激素对这些指标均无影响。在所有终点指标上,R 5020的效果均显著优于孕酮。萘福昔定和MER - 25模拟了雌二醇的作用,使脂肪组织脂蛋白脂肪酶(LPL)活性降低了75 - 80%。对于脂肪组织LPL活性而言,萘福昔定和MER - 25均为完全的雌激素激动剂,且无抗雌激素活性。萘福昔定还通过减少OVX大鼠的食物摄入量、体重和胴体脂肪含量,模拟了EB的作用。相比之下,萘福昔定可拮抗EB在OVX大鼠子宫旁脂肪组织中诱导的细胞质孕激素([3H]R 5020)结合位点。在接受萘福昔定治疗的OVX大鼠中,同时给予孕酮对脂肪组织LPL活性无影响,但孕酮确实增加了食物摄入量、体重和胴体脂肪含量。本文讨论了性腺类固醇可能影响饮食和肥胖的一些生理机制。